secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001493152-23-041393
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM Immunotech files 8-K with Q3 2023 update presentation; no specific data available in filing text
--------------------------------------------------------------------------------

- Filing includes a company presentation as Exhibit 99.1 titled Q3 2023 Update Conference Call and dated November 15, 2023.
- Presentation is furnished under Regulation FD and not filed; no financial or operational details are provided in the 8-K body.
- No specific earnings, revenue, EPS, or guidance figures are available from the furnished content as seen in the filing.
- Ticker: AIM; stock listed on NYSE American.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315223041393/0001493152-23-041393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315223041393/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer